Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
Blood|September 27, 2013
JAK2 p.V617F detection and allele burden measurement in peripheral blood and bone marrow aspirates in patients with myeloproliferative neoplasmsKoichi Takahashi, Keyur P Patel, Hagop Kantarjian, et al.
Acta Haematologica|November 22, 2018
Unique Case of Myeloproliferative Neoplasm with Two Rare Clonal Abnormalities: Rare JAK2 Exon 12 Mutation and Rare e14a3 (b3a3) BCR/ABL Fusion TranscriptMahesh Swaminathan, Keyur P Patel, Julie Huynh-Lu, et al.
Blood|March 22, 2015
Secondary mutations as mediators of resistance to targeted therapy in leukemiaNaval Daver, Jorge Cortes, Farhad Ravandi, et al.
Case Reports in Pathology|November 22, 2021
Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Clinicopathologic Analysis with Evaluation of the E-Cadherin/β-Catenin Complex and Associated Genetic AlterationsMaria Del Valle Estopinal, Lavinia P Middleton, Bita Esmaeli, et al.
Expert Review of Molecular Diagnostics|January 15, 2016
Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratoryRashmi Kanagal-Shamanna, Rajesh R Singh, Mark J Routbort, et al.
American Journal of Clinical Pathology|December 22, 2010
Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic featuresKeyur P Patel, Farhad Ravandi, Deqin Ma, et al.
Hematology/Oncology and Stem Cell Therapy|February 8, 2018
Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantationAron Simkins, Abhishek Maiti, Nicholas J Short, et al.
The Journal of Molecular Diagnostics : JMD|September 6, 2011
Diagnostic testing for IDH1 and IDH2 variants in acute myeloid leukemia an algorithmic approach using high-resolution melting curve analysisKeyur P Patel, Bedia A Barkoh, Zhao Chen, et al.
The Journal of Molecular Diagnostics : JMD|February 26, 2010
Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangementsKeyur P Patel, Qiulu Pan, Yanhua Wang, et al.
Molecular Cancer Therapeutics|April 27, 2018
Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted TherapyHui Chen, Rajyalakshmi Luthra, Mark J Routbort, et al.
Pageof 23